Does TEPOTINIB Cause Off label use? 42 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Off label use have been filed in association with TEPOTINIB (TEPMETKO). This represents 6.3% of all adverse event reports for TEPOTINIB.
42
Reports of Off label use with TEPOTINIB
6.3%
of all TEPOTINIB reports
11
Deaths
10
Hospitalizations
How Dangerous Is Off label use From TEPOTINIB?
Of the 42 reports, 11 (26.2%) resulted in death, 10 (23.8%) required hospitalization, and 1 (2.4%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEPOTINIB. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does TEPOTINIB Cause?
Death (117)
Oedema peripheral (82)
Diarrhoea (57)
Renal impairment (57)
Oedema (56)
Fatigue (53)
Disease progression (50)
Nausea (43)
Peripheral swelling (32)
Blood creatinine increased (30)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TEPOTINIB Alternatives Have Lower Off label use Risk?
TEPOTINIB vs TEPROTUMUMAB
TEPOTINIB vs TEPROTUMUMAB-TRBW
TEPOTINIB vs TERAZOSIN
TEPOTINIB vs TERAZOSIN\TERAZOSIN
TEPOTINIB vs TERBINAFINE